The Online Investor
Grifols SA, Barcelona (GRFS)

Grifols is engaged in developing, manufacturing and distributing a range of biological medicines on plasma derived proteins. Co. organizes its business into five divisions: Bioscience, which includes activities relating to the manufacture of plasma derivatives for therapeutic use; Diagnostic, which focuses on researching, developing, manufacturing and marketing in vitro diagnostics products; Hospital, which manufactures products used by hospitals, as well as parenteral solutions and enteral nutritional fluids; Bio Supplies, which is primarily involved in biological products for non-therapeutic use; and Others, which is primarily involved in manufacturing services to third party companies.
Company Name: 
Grifols SA, Barcelona
Drugs & Pharmaceuticals
Number of ETFs Holding GRFS: 
Total Market Value Held by ETFs: 

Quotes delayed 20 minutes

Email EnvelopeFree GRFS Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Hold (2.50 out of 4)
0th percentile
(ranked lower than approx. 100% of all stocks covered)

Analysts' Target Price:
GRFS Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Grifols SA, Barcelona (GRFS) Page | The Online Investor Page |

Copyright © 1998 - 2021, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.